Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27 USD | -3.23% | +5.88% | +134.78% |
Mar. 14 | VTv Therapeutics Inc. Announces Board Changes | CI |
Mar. 13 | VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 16
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CEO | Chief Executive Officer | 66 | 22-07-31 |
Steven Tuch
DFI | Director of Finance/CFO | 56 | 22-12-07 |
Vanessa McDade
ADM | Chief Administrative Officer | - | - |
Thomas Strack
CTO | Chief Tech/Sci/R&D Officer | - | Nov. 01 |
Carmen Valcarce
CTO | Chief Tech/Sci/R&D Officer | - | 06-12-31 |
Richard Nelson
BRD | Director/Board Member | 54 | 20-11-15 |
Jennifer Freeman
PRN | Corporate Officer/Principal | - | - |
Barry Brown
AUD | Comptroller/Controller/Auditor | 63 | 22-02-28 |
General Counsel | 58 | 23-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | Feb. 26 | |
Paul Sekhri
CEO | Chief Executive Officer | 66 | 22-07-31 |
Richard Nelson
BRD | Director/Board Member | 54 | 20-11-15 |
Raymond Cheong
BRD | Director/Board Member | 42 | Feb. 26 |
Director/Board Member | 45 | 22-07-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 577,349 | 0 | 0 | 49.45 % |
Stock B | 1 | 2,432,857 | 1,488,481 ( 61.18 %) | 0 |
Company contact information
vTv Therapeutics, Inc.
3980 Premier Drive Suite 310
27265, High Point
+336 841 0300
http://www.vtvtherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+134.78% | 67.88M | |
-1.43% | 102B | |
+2.56% | 96.09B | |
+2.13% | 22.28B | |
-16.46% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.89% | 16.09B | |
+5.32% | 13.83B | |
+33.52% | 11.97B |
- Stock Market
- Equities
- VTVT Stock
- Company vTv Therapeutics Inc.